Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.

导出 LinkOut

翻译打印收藏纠错

作者： Shingo,Kitagawa ^[1] ; Yoshitaka,Zenke ^[2] ; Tetsuro,Taki ^[3] ; Keiju,Aokage ^[4] ; Tetsuya,Sakai ^[2] ; Yuji,Shibata ^[2] ; Hiroki,Izumi ^[2] ; Kaname,Nosaki ^[2] ; Shigeki,Umemura ^[2] ; Shingo,Matsumoto ^[2] ; Kiyotaka,Yoh ^[2] ; Naoya,Sakamoto ^[3] ; Shingo,Sakashita ^[3] ; Motohiro,Kojima ^[3] ; Masahiro,Tsuboi ^[4] ; Koichi,Goto ^[2] ; Genichiro,Ishii ^[5]

作者单位： Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. ^[1] Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. ^[2] Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan. ^[3] Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan. ^[4] Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: gishii@east.ncc.go.jp. ^[5]

关键词 Cancer associated fibroblasts (CAFs)EGFR mutation Lung adenocarcinoma Predominant subtype Tumor associated macrophages (TAMs)Tumor microenvironment